MTORシグナリングはストレス誘発型変異を誘導し,がんの適応的進化を促進する
Arcadi Cipponi1,2, David L Goode3,4, Justin Bedo5,6,7
1The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. a.cipponi@garvan.org.au d.thomas@garvan.org.au.
まとめ
ストレス誘発変異 (SIM) は 微生物が厳しい環境に適応するのを助けます ヒトのがんでは,SIMはMTORを含む2段階の適応プロセスを経て薬剤耐性を誘発し,新しい治療戦略を示唆します.
科学分野:
- 癌 生物学
- 遺伝学
- 進化生物学
背景:
- ストレス誘発変異 (SIM) は微生物の適応のための保存されたメカニズムです.
- 同じようなプロセスが 癌の進行と治療の失敗に 寄与するかもしれません
研究 の 目的:
- ヒトのがん薬剤耐性における SIM の役割を調査する.
- 癌にSIMを媒介する分子機構を特定する.
- 薬剤耐性および潜在的な治療介入のモデルを提案する.
主な方法:
- in vitroおよびin vivoのがんモデルを使用した.
- 非遺伝子毒性薬の選択を適用した.
- ゲノム分析を行いました
- ラパミシン (MTOR) 経路のメカニズム的標的を調査した.
主要な成果:
- SIMは薬物の選択の下での癌の適応を高めます. 本質的な健康コストにもかかわらずです.
- MTORはストレスを感知するレオスタットとして働き,様々な癌のSIMを調節します.
- 薬剤耐性の2段階モデルが観察された:初期多様性の拡大に適応.
結論:
- SIMはがん薬剤耐性の重要な要因です.
- MTORはがんにおけるSIMの重要な媒介です.
- MTORをターゲットにしたり,合成の致命的な戦略を用いることで,薬剤耐性を克服することができます.
関連する概念動画
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Mismatch Repair
6.1K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.1K
Mismatch Repair
43.3K
Overview
43.3K
Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K


